NO20075199L - Treatment or prevention of pruritus - Google Patents

Treatment or prevention of pruritus

Info

Publication number
NO20075199L
NO20075199L NO20075199A NO20075199A NO20075199L NO 20075199 L NO20075199 L NO 20075199L NO 20075199 A NO20075199 A NO 20075199A NO 20075199 A NO20075199 A NO 20075199A NO 20075199 L NO20075199 L NO 20075199L
Authority
NO
Norway
Prior art keywords
pruritus
treatment
prevention
oxaprozin
medicaments
Prior art date
Application number
NO20075199A
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Astion Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Pharma As filed Critical Astion Pharma As
Publication of NO20075199L publication Critical patent/NO20075199L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen tilveiebringer fremgangsmåter og medikamenter for behandling av pruritus generelt, eller pruritus forårsaket av eller forbundet med dermatologiske sykdommer, herunder behandling av den underliggende sykdommen ved topisk administrasjon på huden eller ved systemisk administrasjon av Oxaprozin eller en nært beslektet forbindelse eller salt derav til et individ.
NO20075199A 2005-03-30 2007-10-11 Treatment or prevention of pruritus NO20075199L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200500437 2005-03-30
DKPA200500438 2005-03-30
US69477405P 2005-06-27 2005-06-27
DKPA200500948 2005-06-27
DKPA200500949 2005-06-27
US69504005P 2005-06-28 2005-06-28
PCT/DK2006/000180 WO2006102899A2 (en) 2005-03-30 2006-03-30 Oxaprozin or closely related compound for the treatment and prevention of

Publications (1)

Publication Number Publication Date
NO20075199L true NO20075199L (no) 2008-01-02

Family

ID=36215671

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20075199A NO20075199L (no) 2005-03-30 2007-10-11 Treatment or prevention of pruritus
NO20075227A NO20075227L (no) 2005-03-30 2007-10-12 Treatment of eczemas
NO20075218A NO20075218L (no) 2005-03-30 2007-10-12 Dermatological compositions and salts for the treatment of dermatological diseases

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20075227A NO20075227L (no) 2005-03-30 2007-10-12 Treatment of eczemas
NO20075218A NO20075218L (no) 2005-03-30 2007-10-12 Dermatological compositions and salts for the treatment of dermatological diseases

Country Status (12)

Country Link
EP (3) EP1707200A1 (no)
JP (3) JP2008534526A (no)
KR (3) KR20080005525A (no)
AU (3) AU2006228869A1 (no)
BR (3) BRPI0609535A2 (no)
CA (3) CA2605121A1 (no)
EA (3) EA200702026A1 (no)
EC (3) ECSP077845A (no)
IL (3) IL186021A0 (no)
MX (3) MX2007012052A (no)
NO (3) NO20075199L (no)
WO (3) WO2006102898A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821537D0 (en) * 2008-11-25 2008-12-31 Union Life Sciences Ltd Therapeutic target
WO2017045081A1 (en) * 2015-09-18 2017-03-23 Delivra Inc. Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
EP3496681A4 (en) 2016-08-08 2020-07-22 Avedro, Inc. SYSTEMS AND METHODS FOR CROSSLINKING TREATMENT OF DRY EYES
JP7199096B2 (ja) 2016-10-25 2023-01-05 ティキュア リミテッド 皮膚疾患における治療標的としてのｆａｂｐ４
CA3083786A1 (en) * 2017-12-07 2019-06-13 Dermavant Sciences GmbH Topical ointment formulations of pde-4 inhibitor and their use in treating skin conditions
RU2685436C1 (ru) * 2018-06-22 2019-04-18 ЗАО "ФармФирма "Сотекс" Трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей
JP7514598B2 (ja) * 2018-12-20 2024-07-11 小林製薬株式会社 皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
US3578671A (en) 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4659728A (en) 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6090834A (en) * 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
PL314036A1 (en) 1993-10-20 1996-08-05 Boots Co Plc Pharmaceutical composition
JPH07316075A (ja) 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
GB9606429D0 (en) 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
IL126998A (en) * 1996-05-20 2003-12-10 Searle & Co Potassium, sodium or tris oxaprozin salt pharmaceutical formulations
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050232957A1 (en) 2004-04-14 2005-10-20 Katz Kenneth A Compositions and methods for moisturizing skin

Also Published As

Publication number Publication date
KR20080005525A (ko) 2008-01-14
EP1707200A1 (en) 2006-10-04
KR20080005526A (ko) 2008-01-14
IL186021A0 (en) 2008-02-09
BRPI0607648A2 (pt) 2009-09-22
ECSP077846A (es) 2008-02-20
JP2008534526A (ja) 2008-08-28
JP2008534527A (ja) 2008-08-28
WO2006102898A3 (en) 2006-12-28
ECSP077843A (es) 2008-02-20
ECSP077845A (es) 2008-02-20
NO20075218L (no) 2007-12-27
MX2007012052A (es) 2008-02-22
EP1707201A1 (en) 2006-10-04
AU2006228871A1 (en) 2006-10-05
EA200702027A1 (ru) 2008-02-28
WO2006102899A2 (en) 2006-10-05
EP1707199A1 (en) 2006-10-04
IL186020A0 (en) 2008-01-20
WO2006102900A1 (en) 2006-10-05
NO20075227L (no) 2007-12-09
MX2007012051A (es) 2008-02-22
AU2006228870A1 (en) 2006-10-05
AU2006228869A1 (en) 2006-10-05
JP2008534528A (ja) 2008-08-28
KR20080011280A (ko) 2008-02-01
BRPI0609535A2 (pt) 2010-04-13
WO2006102899A3 (en) 2006-12-28
MX2007012050A (es) 2008-03-11
BRPI0609653A2 (pt) 2010-04-20
EA200702026A1 (ru) 2008-04-28
WO2006102898A2 (en) 2006-10-05
EA200702023A1 (ru) 2008-04-28
IL186022A0 (en) 2008-02-09
CA2605121A1 (en) 2006-10-05
CA2603300A1 (en) 2006-10-05
CA2603297A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
NO20075199L (no) Treatment or prevention of pruritus
EA200971053A1 (ru) Способы лечения кожных язв
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
WO2009050506A3 (en) Combination 059
MX338338B (es) Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
NO20082790L (no) Behandling av type 2 diabetes med en kombinasjon av DPIV inhibitor og metformin eller thiazolidindion
ATE529113T1 (de) Salze von kalium-atp-kanal-öffnern und ihre verwendungen
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
EA201100621A1 (ru) Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством
DE602007004849D1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
WO2009068659A3 (en) Novel disease treatment by predicting drug association
ATE543492T1 (de) Behandlung von lungenkrebs
WO2006108679A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer
NO20076405L (no) Anvendelse av 24-nor-UDCA
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application